Genentech has turned to a biotech startup in New York for its latest discovery pact. The big Roche group is lending its marquee status to little Lodo Therapeutics, which is plumbing microbial DNA sequence information contained in soil for fresh leads on novel therapeutics.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,